Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kathryn I Sunthankar"'
Autor:
Kathryn I Sunthankar, Kevin N Griffith, Stephanie D Talutis, Amy K Rosen, David B McAneny, Matthew H Kulke, Jennifer F Tseng, Teviah E Sachs
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0237439 (2020)
Patients who are incarcerated are a vulnerable patient population and may suffer from less access to routine cancer screenings compared to their non-incarcerated counterparts. Therefore, a thorough evaluation of potential differences in cancer diagno
Externí odkaz:
https://doaj.org/article/d87d445ee67d4a429142322434d61e0a
Autor:
Rozi Khan, Kathryn I. Sunthankar, Abdul Qahar Khan Yasinzai, Bisma Tareen, Muhammad Samsoor Zarak, Jaffar Khan, Hassan Nasir, Manando Nakasaki, Eiman Jahangir, Saleh Heneidi, Asad Ullah
Publikováno v:
Clinical Research in Cardiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffe269822985837fc8c2649a868eafc8
https://doi.org/10.1007/s00392-023-02236-x
https://doi.org/10.1007/s00392-023-02236-x
Autor:
Sweta B. Patel, Kathryn I. Sunthankar, P. Brent Ferrell, Matthew T. Jenkins, Robert S. Welner, Candace H. Cote
Publikováno v:
Leukemia
Mutations in isocitrate dehydrogenase 2 (IDH2) have been noted to impact cellular differentiation in addition to DNA and histone methylation. However, little is known about the impact of IDH2 mutations on intracellular signaling. Using an isogenic ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82543fd8606e71332722fba4c13d0911
https://europepmc.org/articles/PMC9066619/
https://europepmc.org/articles/PMC9066619/
Autor:
Jennifer F. Tseng, Kathryn I. Sunthankar, David McAneny, Matthew H. Kulke, Amy K. Rosen, Kevin N. Griffith, Teviah E. Sachs, Stephanie D. Talutis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 9, p e0237439 (2020)
PLoS ONE, Vol 15, Iss 9, p e0237439 (2020)
Patients who are incarcerated are a vulnerable patient population and may suffer from less access to routine cancer screenings compared to their non-incarcerated counterparts. Therefore, a thorough evaluation of potential differences in cancer diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba14eecc98d87b4b59d0e69d06de51ad
http://europepmc.org/articles/PMC7491712
http://europepmc.org/articles/PMC7491712
Autor:
M. Pia Arrate, Matthew T. Jenkins, Merrida A Childress, Kathryn I. Sunthankar, Michael R. Savona, Melissa A. Fischer, Agnieszka E. Gorska, Haley E. Ramsey, Matthew T. Villaume, Brianna N Smith, Tamara K. Moyo, P. Brent Ferrell
Publikováno v:
Experimental Hematology. 97:57-65.e5
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome characterized by monocytic proliferation in the presence of dysplastic bone marrow changes, inflammatory symptoms, and propensity for tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64a464e4fe3a026c543f0140160abace
https://doi.org/10.1016/j.exphem.2021.02.008
https://doi.org/10.1016/j.exphem.2021.02.008